COLUMBIA, S.C., Dec. 1 /PRNewswire-FirstCall/ -- Collexis Holdings, Inc.
(OTC Bulletin Board: CLXS), a leading developer of semantic search and
knowledge discovery software, announced today a partnership with BioFlorida,
Inc., Florida's statewide bioscience association, to promote BiomedExperts.com
to the association's 200+ membership base. Through the partnership,
BiomedExperts.com will serve as the primary professional network for
BioFlorida, helping to facilitate collaboration and advance scientific
discovery among its member researchers.
BiomedExperts.com is the world's first literature-based professional
social networking site that was pre-populated with more than 1.8 million
expert profiles from PUBMED. The site allows scientists and researchers to
directly connect with and explore their professional contacts, grow their
networks and identify researchers with the expertise needed for future
collaborations. With 60,000+ registered users worldwide, BiomedExperts.com
provides user-friendly interfaces through which research collaborators can
share data and network with 1,800 organizations and institutions from 137
countries, totaling more than 21 million connections made through the site.
"Meeting the demands of Florida's ever-growing bioscience industry can be
quite a challenge. Collexis' BiomedExperts.com will assist us in overcoming
issues associated with those challenges," said Russell Allen, BioFlorida's
president & CEO. "Choosing BiomedExperts.com as our primary professional
network will allow us to introduce our membership to BiomedExperts.com ever
growing community. The network will enable our members to track the latest
research in life sciences, and connect with leading industry experts."
"We are excited about this partnership with BioFlorida and its selection
of BiomedExperts.com to further enable collaboration among its members," said
Collexis CEO Bill Kirkland. "Collexis' technology will be a valuable asset to
the association and its overall mission. Working together with BioFlorida, we
will leverage their members' expertise in all areas of the bioscience industry
to help advance research throughout Florida and beyond."
About BioFlorida, Inc.
BioFlorida is Florida's statewide trade association for the bioscience
industry providing advocacy, business development and communications services
for more than 200 member companies. Our mission is to be the voice of the
bioscience industry and the advocate for our member organizations-both large
and small. Bringing knowledge and resources to Florida's bioscience community,
BioFlorida supports the health, agricultural and energy sectors of
biotechnology as well as the pharmaceutical and medical technology fields. For
more information, visit bioflorida.com .
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and
knowledge discovery software is headquartered in Columbia, South Carolina
(USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands
and Cologne, Germany. Collexis now offers the world's first pre-populated
scientific social network for life science researchers,
www.biomedexperts.com . Collexis' proprietary technology builds conceptual
profiles of text, called Fingerprints, from documents, Websites, emails and
other digitized content and matches them with a comprehensive list of
pre-defined "fingerprinted" concepts to make research results more relevant
and efficient. This matching of concepts eliminates the ambiguity and lack of
priority associated with word searches. The results are often described as
"finding needles in many haystacks." Through this novel approach, Collexis can
build unique applications to search, index and aggregate information as well
as prioritize, trend and predict data based on sources in multiple industries
without the limitations of language or dialect. Collexis' current clients in
the public, private and academic sectors include the Mayo Clinic; Johns
Hopkins University; Dana-Farber Cancer Institute, the University of
California, San Francisco; the University of South Carolina; Erasmus
University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health
Organization; Wellcome Trust; the National Institutes of Health; and the U.S.
Department of Defense. Shares of Collexis common stock are traded under the
symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit
www.collexis.com .
Forward-Looking Statements
Some of the statements made in this press release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which the company is unable to
predict or control, that may cause the company's actual results or performance
to differ materially from any future results or performance expressed or
implied by such forward-looking statements. These statements involve risks and
uncertainties, including risks and uncertainties associated with the company's
collaboration with BioFlorida. These risks and uncertainties are in addition
to other factors detailed from time to time in the company's filings with the
SEC, including the section entitled "Risk Factors" in its transition report on
Form 10-KSB for the period ended June 30, 2008. The company cautions investors
that any forward-looking statements made by the company are not necessarily
indicative of future performance. The company is not responsible for updating
the information contained in this press release beyond the published date, or
for changes made to this document by wire services or Internet services.
SOURCE Collexis Holdings, Inc.